Publication

Phase 1’s future in the UK

Phase I is the lifeblood or new medicines. The UK’s Phase I representative body,

Read More
Exacerbation and risk factors in severe asthma

Asthma is a chronic inflammatory disorder of the airways

Read More
Ready! Aim! Fire!

Since 2013 we have been sharing our understanding on key issues with friends and clients via our Insider’s Insights.

Read More
A simple polymeric small molecule from the 70's versus COVID-19?

There have been hundreds of thousands of deaths from COVID-19

Read More
A survey to inform working practices

The sudden imposition of remote working in response to the 2020 COVID-19

Read More
Will you be frail in old age?

Phenotype-specific omic expression patterns in people with frailty could provid

Read More
Type 2 dipeptidyl peptidase‐4 inhibitors, SARS‐CoV‐2 and cockroaches

The comparison of the DPP4 (dipeptidyl peptidase 4) SARS-CoV-2

Read More
I love it when a plan...

In this case the plan is a paradigm shift in the way we will manage

Read More
Clinical pharmacologists prepare for change

The latest issue of Journal Frontiers in Pharmacology has just published

Read More
A EUFEMED achievement

I'm sure that everyone works hard and tries to do their best.

Read More
1 2 3

Get our latest news and publications

Sign up to our news letter

© 2025 Niche.org.uk     All rights reserved

HomePrivacy policy Corporate Social Responsibility